SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCompre Grp.28 Regulatory News (RG62)

Share Price Information for Compre Grp.28 (RG62)

Share Price is delayed by 15 minutes
Get Live Data
0.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
RG62 Live PriceLast checked at - London Stock Exchange

Intraday Compre Grp.28 Share Chart

Compre and Accelerant execute legacy transaction

22 Aug 2024 17:19

RNS Number : 4924B
Compre Group Holdings Limited
22 August 2024
 

 

 

 

 

Press release

 

22 August 2024

 

Compre and Accelerant execute legacy transaction

 

Compre Group Holdings Limited ("Compre"), the Bermuda-domiciled international legacy and reinsurance group, today announced it has completed a legacy reinsurance transaction with Accelerant, the data-driven risk exchange, following approval by the Bermuda Monetary Authority. The transaction, which has been underwritten by Compre's Bermuda-based reinsurer Pallas Reinsurance Company Ltd., will provide approximately $150 million of cover on loss reserves.

 

The portfolio comprises a broad mix of US and European property & casualty liabilities, providing cover for Accelerant's retention on the 2020 and 2021 underwriting years. Compre will also offer terms for future underwriting years as these become sufficiently developed.

 

The deal was brokered by Augment Risk and Compre's legal advisers were the UK and US based teams from Willkie Farr & Gallagher.

 

Will Bridger, CEO, Compre said: "This transaction demonstrates our ability to create a structured reinsurance solution that supports Accelerant's strategic objectives. We look forward to our continued partnership with them."

 

Jeff Radke, CEO of Accelerant said: "As we work to replatform the insurance industry, this marks another important step in the development of our Risk Exchange."

 

Andrew Matson, CEO, Augment Risk, said: "We are pleased to have been able to assist Accelerant on this pioneering transaction. It reflects our commitment to creating long-term retrospective partnerships, and more broadly highlights the importance of bespoke capital solutions as part of the value chain."

 

 

- Ends -

 

For further information please contact:

Compre

David Haggie / Richard Adams / Olivia Thomson, Haggie Partners

compre@haggie.co.uk 

+44 20 7562 4444

 

Accelerant

Chelsea Allison

chelsea@cmand.co

312.775.2856

 

 

Augment Risk

Molly Griffin

+447960402330

molly.griffin@augmentrisk.com

 

About Compre:

Compre is a leading legacy specialist with more than 30 years of experience in the acquisition and management of discontinued and legacy non-life insurance and reinsurance business. Compre has experience of acquiring most classes of direct and reinsurance business, including general liability, marine and motor liability, and US APH. Compre has operations in Bermuda, Finland, Germany, Ireland, Malta, Switzerland, UK, USA and at Lloyd's. www.compre-group.com

 

About Accelerant:

Accelerant is a data-driven risk exchange connecting underwriters of specialty insurance risk with risk capital providers. Accelerant was founded in 2018 by a group of long-time insurance industry executives and technology experts who shared a vision of rebuilding the way risk is exchanged - so that it works better, for everyone. The Accelerant Group was awarded an "A-" financial strength rating by A.M. Best which recently affirmed the Group's stable outlook. accelerant.ai

 

 

About Augment Risk:

Augment Risk is an innovative risk capital and reinsurance solutions broker, focused on designing and placing bespoke protections for a variety of clients. With a wide range of solutions, Augment Risk creates growth and equity value through tailored transactions to deliver long-term capital and partnerships. Augment Risk's expertise extends beyond reinsurance, allowing the company to disrupt the value chain and build creative, value-accretive solutions for individual client needs. For more information, please visit www.augmentrisk.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CIRBLGDIRBDDGSD
Date   Source Headline
8th Jun 20263:16 pmRNSSenior Management Change
14th Apr 20269:02 amRNSCompre announces FY 2025 results
6th Feb 202612:11 pmRNSCompre Appoints David Atkins as Deputy CEO
12th Nov 20258:00 amRNSSenior Management Change
30th Sep 20257:56 amRNSInterim Financial Report - 30 June 2025
14th May 202511:17 amRNSCompre completes portfolio transfer from Ethias
17th Apr 20257:56 amRNSCompre announces FY 2024 results
16th Apr 20259:00 amRNSCompre acquires Covéa US subsidiary
13th Mar 20252:10 pmRNSCompre appoints John Howard as chairman
7th Feb 20255:00 pmRNSBoard and Senior management changes
12th Sep 20248:00 amRNSInterim Financial Report - 30 June 2024
22nd Aug 20245:19 pmRNSCompre and Accelerant execute legacy transaction
15th Aug 20247:00 amRNSCompre announces change of registered address
3rd Jun 20247:00 amRNSCompre reports record results in ‘landmark’ year
10th Jan 20249:00 amRNSCompre acquires two European liability portfolios
30th Nov 20234:37 pmRNSCompre appoints two new members to Group Board
11th Oct 20232:12 pmRNSInterim Financial Report - 30 June 2023
10th Oct 20234:55 pmRNSInterim Financial Report - 30 June 2023
4th Sep 20239:00 amRNSCompre completes acquisition of Covéa subsidiary
3rd Jul 20231:15 pmRNSSiriusPoint and Compre complete LPT transaction
22nd May 20237:40 amRNSCompre acquires workers’ comp portfolio from SUNZ
12th May 20231:45 pmRNSAudited Annual Financial Report - 31 December 2022
2nd Mar 20231:32 pmRNSCompre announces second deal with SiriusPoint
20th Oct 20227:00 amRNSCompre agrees to acquire subsidiary from Covéa
25th Aug 20228:22 amRNSCompre acquires further MedMal portfolio
15th Aug 20227:00 amRNSCompre acquires German liability portfolio

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.